ETON · Company research
Eton Pharmaceutcials, Inc. Common Stock (ETON): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Responsive Playbooks and the ETON Inflection - Stock Traders Daily | Responsive Playbooks and the ETON Inflection Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals (NASDAQ:ETON) Stock Rating Reaffirmed as Buy by HC Wainwright - MarketBeat | Eton Pharmaceuticals (NASDAQ:ETON) Stock Rating Reaffirmed as Buy by HC Wainwright MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug - Benzinga | Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug Benzinga | View source ↗ | Benzinga | Oct 14, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals (NASDAQ:ETON) Stock Jumps 5.1% - Should You Buy? - MarketBeat | Eton Pharmaceuticals (NASDAQ:ETON) Stock Jumps 5.1% - Should You Buy? MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| Aquestive rises on licensing deal with Eton (ETON:NASDAQ) - Seeking Alpha | Aquestive rises on licensing deal with Eton (ETON:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 14, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. License Agreement for LIBERVANT Buccal Film for Seizure Clusters - Quiver Quantitative | Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. License Agreement for LIBERVANT Buccal Film for Seizure Clusters Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 14, 2026 | neutral | 0 | 0.6 |
| 71% of surveyed patients preferred seizure-rescue film to nasal spray, assuming both worked equally well. - Stock Titan | 71% of surveyed patients preferred seizure-rescue film to nasal spray, assuming both worked equally well. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals CBO David Krempa sells $229k in stock - Investing.com | Eton Pharmaceuticals CBO David Krempa sells $229k in stock Investing.com | View source ↗ | Investing.com | Oct 11, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals (ETON) Launches IMPAVIDO, Is The Stock Still Undervalued? - Simply Wall Street | Eton Pharmaceuticals (ETON) Launches IMPAVIDO, Is The Stock Still Undervalued? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Stocktwits | This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| ETON Stock Surges 108% in Six Months: Here's What You Need to Know - Zacks Investment Research | ETON Stock Surges 108% in Six Months: Here's What You Need to Know Zacks Investment Research | View source ↗ | Zacks Investment Research | Oct 7, 2026 | neutral | 0 | 0.6 |
| ETON Stock Surges 108% in Six Months: Here's What You Need to Know | Eton Pharmaceuticals has gained 108% over six months, driven by 99% Q2 product sales growth and successful Hemangeol relaunch. The company raised 2026 revenue guidance to above $145 million with 35%+ adjusted EBITDA margins. Pipeline expansion including new launches and late-stage candidates like ASN-001 provide additional growth opportunities. | View source ↗ | Zacks Investment Research | Oct 7, 2026 | bullish | 0.25 | 1 |
| ETON Stock Surges 108% in Six Months: Here's What You Need to Know - Yahoo Finance | ETON Stock Surges 108% in Six Months: Here's What You Need to Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 7, 2026 | neutral | 0 | 0.6 |
| ETON Stock Jumps 10%: Why Does This Analyst See 47% Upside To Stock? - Stocktwits | ETON Stock Jumps 10%: Why Does This Analyst See 47% Upside To Stock? Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals (NASDAQ:ETON) Insider Sells $229,421.62 in Stock - MarketBeat | Eton Pharmaceuticals (NASDAQ:ETON) Insider Sells $229,421.62 in Stock MarketBeat | View source ↗ | MarketBeat | Oct 6, 2026 | neutral | 0 | 0.6 |
| To cover stock-grant vesting, Eton Pharmaceuticals (ETON) officer proposes selling 4,166 shares. - Stock Titan | To cover stock-grant vesting, Eton Pharmaceuticals (ETON) officer proposes selling 4,166 shares. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| ETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights - Timothy Sykes | ETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights Timothy Sykes | View source ↗ | Timothy Sykes | Oct 3, 2026 | neutral | 0 | 0.6 |
| $ETON stock is down 15% today. Here's what we see in our data. - Quiver Quantitative | $ETON stock is down 15% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 30, 2026 | neutral | 0 | 0.6 |
| Why Eton Pharmaceuticals Is Top of the Class Today - The Motley Fool | Why Eton Pharmaceuticals Is Top of the Class Today The Motley Fool | View source ↗ | The Motley Fool | Aug 14, 2026 | neutral | 0 | 0.6 |
| This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Yahoo Finance | This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| Eton Pharmaceuticals: Here Is How I Handle My Position With The Stock Skyrocketing (Downgrade) - Seeking Alpha | Eton Pharmaceuticals: Here Is How I Handle My Position With The Stock Skyrocketing (Downgrade) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 22, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.